FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Autor: Sara Mireya Chernilo Steinmann, Abel Jasovich, Ivars Krastins, Osvaldo Teglia, Viktors Lovcinovsk, Rashad Abyshev, Graciana Isabel Morera, Maria del Rosario Gonzalez Arzac, Dorota Górecka, Thomas Mueller, Janos Szegedi, Violetta Labij, Amal Kumar Bhattacharya, Diego Maurizi, Manuel Jose Barros Monge, Parthiv Mehta, Mario Andres Calvo Arellano, Zsolt Pápai-Székely, K.N. Mohar Rao, Moises Acuna Kaldman, Peter Kujath, F.J. Meyer, Mahabala Chakrapan, Alexander Gorelov, Piotr Nalepa, Valdimir Hodzhev, Gerardo Amaya Tapia, Vladislav Novozhenok, Oliver Schmalz, Lily Llorens, Norbert Vetter, Eduardo Noriega, Dimitar Popov, Vita Svarcberga, Deepak Talwar, Joachim Bargon, Dirk Thye, Ricardo Lamberghini, Valentina Ionescu, Achim Lies, Maria Antonia Mastruzzo, V O Sushko, Tom Schaberg, Jerzy Kozielski, Jorge Corral, Barbara Rogala, Pablo Antonio Gaete Gutierrez, Alla L. Esina, Wolfgang Schütte, María Eugenia Oliva, Roman S. Kozlov, Carolina Eugenia Chahin Anania, Angel Ramon Minguez, Ognian Georgiev, Konstantin Zhidkov, Josef Bolitschek, Vadim Vizir, Thorsten Bauer, Sven Glaeser, Ian A. Critchley, Oleksandr Dziublyk, Jon Lee, Analia Mykietiuk, Carlos Ramos, Georgiy V. Dzyak, Stefan Krueger, Hanna Szelerska-Twardosz, George H. Talbot, Mihai Marius Muresan, Mykhaylo Borscchivskyy, Christian G. Remolif, Oleg A. Khrustalev, Adam Antczak, Yuriy M. Mostovoy, Pabio Gustavo Scapellato, Rosen Marinov, Oleg Kraydaschenko, Tomasz Grodzicki, H. David Friedland, George D'Souza, Milkana Simeonova, Rafal Harat, Svetlana Sobchenko, Hartmut Kern, Javier Altclas, Eduardo Demetrio Matos Prado, Arturo Jauregui Cruz, Marinka Peneva, Vasily Trofimov, Sergey Yakovlev, Tomasz Kachel, Veronika B. Popova, Maria Isabel Enriqueta Campos Barker, Rolf Bergmann, Ryszarda Chazan, Carmen Georgeta Fierbinteau, Peter Hammerl, Sándor Molnár, Andrzej Szczeklik, Paul B. Eckburg, Janusz Milanowski, Karina Jahnz—Rö, Tobias Welte, Viesturs Silins, Iwona Grzelewska—Rzymowska, Josef Eckmayr, Bernard Panaszek, Irina Andreeva, Eduardo Giugno, Luminta Gabriela Ambert, Sylvia Susana Muñoz Vejar, Jacek Juszczak, Ilona Vinkler, Carlos E. Bergallo, Malgorzata Wróbel-Rajzer, Marina Balyuzek, Yuri A. Antonovsky, Dariusz Jastrzebsk, G.S. Malpani, Cristina Mihaela Tanaseanu, Hristo Metev, Andrzej Marciniak, Donald E. Low, Germán Ambasch, Thomas M. File, Iurii S. Rudyk

Publikováno v: Journal of Antimicrobial Chemotherapy. 66:iii33-iii44

Objectives Ceftaroline (active form of the prodrug ceftaroline fosamil) is a novel cephalosporin with activity against pathogens commonly associated with community-acquired pneumonia (CAP), including Streptococcus pneumoniae and Gram-negative pathoge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4984415e3d63f3ff3d554a545309a453
https://doi.org/10.1093/jac/dkr097